GLMD my own DD

Been digging into the latest developments and GLMD looks like it’s evolving into something way bigger than people realize.

1. They just dropped a new biomarker signature from their Phase 3 ARMOR study it’s showing effects beyond just liver stuff, lower inflammation, cardiac stress, fibrosis markers, etc. This could open doors to much more than NASH.

2. They’re also now working with VCU on GI cancers, testing Aramchol in drug resistant colorectal and liver cancers. That’s huge totally new angle for the company.

3. Their new Meglumine formulation (Part 1 done) has 2x the absorption, and the IND is already approved for Part 2 in H2 2025. Plus, this extends patent protection to 2035 gives them a solid runway.

This isn’t just a NASH play anymore. GLMD is turning into a bullish precision, multi indication biotech and it’s still flying under the radar… keep this in your watchlist I have feeling a nice PR is coming soon, is already due for one 🔥